当前位置:首页 - 行情中心 - 毕得医药(688073) - 财务分析

毕得医药

(688073)

  

流通市值:18.75亿  总市值:39.41亿
流通股本:4323.42万   总股本:9088.29万

毕得医药(688073)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.84亿元,每股收益0.94元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益199797.29万元,未分配利润22856.20万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产235216.54万元,负债35419.25万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入811,377,889.62532,207,309.99262,669,977.51,091,858,561.97
营业总成本696,947,815.87456,333,477.22225,411,993.32940,546,450.07
营业利润102,287,565.1764,074,794.6531,187,836.18126,629,167.17
利润总额102,391,559.7964,254,167.5631,310,230.44125,996,771.38
净利润83,853,892.851,839,064.5526,074,943108,446,298.78
其他综合收益3,372,706.74376,362.85-339,064.78282,987.35
综合收益总额87,226,599.5452,215,427.425,735,878.22108,729,286.13
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,160,696,619.692,177,018,736.882,239,748,244.092,261,166,147.47
非流动资产合计191,468,793.21137,128,286.29142,171,264.41153,861,833.35
资产总计2,352,165,412.92,314,147,023.172,381,919,508.52,415,027,980.82
流动负债合计316,007,191.11296,014,511.51296,518,295.05274,970,102.88
非流动负债合计38,185,293.3542,970,044.6140,160,903.6150,515,725.61
负债合计354,192,484.46338,984,556.12336,679,198.66325,485,828.49
归属于母公司股东权益合计1,997,972,928.441,975,162,467.052,045,240,309.842,089,542,152.33
股东权益合计1,997,972,928.441,975,162,467.052,045,240,309.842,089,542,152.33
负债和股东权益合计2,352,165,412.92,314,147,023.172,381,919,508.52,415,027,980.82
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计889,986,877.02591,673,701.61283,642,299.111,207,830,867.32
经营活动现金流出小计789,436,921.65501,996,272.43235,474,799.791,265,218,468.1
经营活动产生的现金流量净额100,549,955.3789,677,429.1848,167,499.32-57,387,600.78
投资活动现金流入小计360,254,145.57143,211,618.41,361,505.0178,041,234.44
投资活动现金流出小计710,003,767.26409,897,389.542,307,488.3106,906,986.43
投资活动产生的现金流量净额-349,749,621.69-266,685,771.14-945,983.29-28,865,751.99
筹资活动现金流入小计112,168,202.1774,733,673.0739,751,310.375,211,234.01
筹资活动现金流出小计247,785,514.5215,498,037.2976,878,054.97143,517,035.93
筹资活动产生的现金流量净额-135,617,312.33-140,764,364.22-37,126,744.6-138,305,801.92
汇率变动对现金及现金等价物的影响-1,339,636.09-101,748.5-922,141.1-5,833,472.13
现金及现金等价物净增加额-386,156,614.74-317,874,454.689,172,630.33-230,392,626.82
期末现金及现金等价物余额878,913,439.7947,195,599.761,274,242,684.771,265,070,054.44
最新报告期:2024-12-02
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中信证券陈竹1.391.712.042024-12-02
华创证券郑辰1.281.832.422024-11-12
财通证券张文录1.261.551.912024-10-25
浙商证券孙建,王帅1.321.752.352024-10-25
开源证券余汝意1.301.471.772024-10-24
TOP↑